We found that all three genes were downregulated, and IRP2 showed a significant positive correlation with RTN4IP1 in thyroid cancer, whereas only RTN4IP1 expression was elevated, and no significant correlation was observed between these three genes in breast cancer (data not shown). This evidence concerns the gene RTN4IP1 and thyroid gland carcinoma.